ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2015 American Transplant Congress

    Outcomes of Kidney Transplantation from Hypertensive Living Donors

    D.-A. Moutzouris, D. Ellis, K. Koutroutsos, R. Charif, J. Galliford, J. McDermott, D. Taube, M. Loucaidou.

    Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.

    The disparity between donor kidney availability and demand has increased utilization of kidneys from marginal living donors, including hypertensive donors. The aim of this study…
  • 2015 American Transplant Congress

    “2mm” Is Reasonable and Feasible Cutoff Value of Indication for Vascular Reconstruction in a Kidney Allograft With Multiple Arteries

    D. Iwami, K. Morita, H. Sasaki, Y. Oishi, H. Higuchi, N. Shinohara.

    Urology, Hokkaido University, Sapporo, Hokkaido, Japan.

    Introduction: Multiple renal arteries are found in 18 to 43% of donor kidneys. We've been using cutoff diameter of <2mm for accessory arteries measured by…
  • 2015 American Transplant Congress

    Molecular Marker Strategies Supporting the Novartis US92 Study- A Discovery Study of Protein Biomarkers for Kidney Function (eGFR) and Acute Rejection in Serum from Renal Transplant Patients

    U. Christians,1 J. Klepacki,1 A. Karimpour-fard,1 G. Ingle,2 D. Patel,2 K. Johnson,3 D. Cibrik,3 J. Klawitter.1

    1University of Colorado, Anschutz Medical Campus, Aurora, CO; 2Novartis Pharmaceuticals, East Hanover, NJ; 3University of Michigan Medical School, Ann Arbor, MI.

    Purpose. Protein biomarkers have the potential to allow for earlier and more specific diagnosis of kidney injury in kidney transplant patients than established clinical markers…
  • 2015 American Transplant Congress

    The Onset of Post-Transplant Malignancies Is Related to a Change in Gene Expression Profiles in Peripheral Blood Mononuclear Cells

    G. Stallone,1 R. Federica,1 P. Pontrelli,2 M. Accetturo,2 A. Oranger,2 M. Gigante,2 G. Castellano,2 A. Schena,2 M. Fiorentino,2 B. Infante,1 L. Gesualdo,2 G. Grandaliano.1

    1Dept.of Surgical and Medical Sciences, Nephrology Unit, University of Foggia, Foggia, Italy; 2Dept. of Emergency and Organ Transplantation, Nephrology Unit, University of Bari, Bari, Italy.

    Malignancies are the third leading cause of death in renal transplant recipients and their incidence is increasing. Although the role of the immune system in…
  • 2015 American Transplant Congress

    Does HLA-Incompatible Transplantation Confer a Survival Advantage in the UK?

    M. Manook,1 Z. Ahmed,1 R. Johnson,2 O. Shaw,1 N. Kessaris,1 A. Dorling,1 N. Mamode.1

    1Renal, Guy's & St Thomas' Hospital, London, United Kingdom; 2NHS Blood & Transplant, Bristol, United Kingdom.

    Introduction: HLA-incompatible transplantation is perceived as being a 'high-risk' option with increased mortality and morbidity for transplantation of sensitized recipients of renal transplants. Data from…
  • 2015 American Transplant Congress

    Clusterin-Regulated Transcriptome in the Kidney During Ischemia-Reperfusion

    G. Dairi, Q. Guan, A. Haegert, C. Collins, M. Gleave, C. Nguan, C. Du.

    Department of Urological Sciences, Vancouver, Canada; The University of British Columbia, Vancouver, Canada; Immunity and Infection Research Centre, Vancouver, Canada; Vancouver Coastal Health Research Institute, Vancouver, Canada.

    BACKGROUND: Ischemia-reperfusion injury (IRI) has a significate impact on both short and long-term transplant outcomes, and is a major cause of delayed graft function in…
  • 2015 American Transplant Congress

    Treatment With Everolimus and Reduced-Exposure Cyclosporine Is Efficacious in De Novo Renal Transplant Recipients at Increased Risk for Efficacy Failure: Post-Hoc Analysis from the A2309 Study

    M. Carmellini,1 V. Garcia,1 Z. Wong,2 M. Vergara,2 C. Escrig,2 G. Russ.1

    1For the A2309 Study Group, Italy; 2Novartis, Basel, Switzerland.

    Purpose: Data is limited on the effect of everolimus (EVR) based regimens in renal transplant recipients (RTxR) who are at increased risk for rejection and…
  • 2015 American Transplant Congress

    Calcineurin Inhibitor-Free Immunossupresion After Kidney Transplantation, Using Everolimus De Novo – Single Center Experience

    M. Stronka, Z. Adamska, L. Cichanska, J. Kubiak, M. Gamrat, M. Karczewski.

    Department of Transplantology, General, Vascular and Plastic Surgery, Clinical Hospital of Poznan University of Medical Sciences, Poznan, Poland.

    The aim of the study was to analyse the clinical outcome in kidney transplant recipients treated with CNI (calcineurin inhibitors)-free protocol versus kidney transplant recipients…
  • 2015 American Transplant Congress

    Long-Term Follow-Up After Conversion from Twice-Daily Tacrolimus Formulation to Once-Daily Tacrolimus Formulation in Pediatric Kidney Transplantation

    C. Choi, A. Han, S. Min, S.-K. Min, T. Lee, I.-M. Jung, S. Kim, J. Ha.

    Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.

    PurposeTacrolimus is one of the most frequently used immunosuppressants in pediatric kidney transplantation (KT) as in adult. In Pediatric kidney recipients, it is more important…
  • 2015 American Transplant Congress

    Program-Effect Attenuation With Time Posttransplant

    N. Salkowski,1 L. Hunsicker,1,2 J. Snyder,1 B. Kasiske.1,3

    1Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN; 2Department of Medicine, University of Iowa, College of Medicine, Iowa City, IA; 3Department of Medicine, University of Minnesota, Minneapolis, MN.

    The program-specific reports produced by SRTR include 1-month, 1-year, and 3-year posttransplant graft and patient survival measures. The 1-month and 1-year measures use the same…
  • « Previous Page
  • 1
  • …
  • 529
  • 530
  • 531

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences